The main results of the trial, published last year in The New England Journal of Medicine , showed a 20% reduction in the risk of MACE in 8,803 participants who took semaglutide, compared with 8,801 participants who took an identical-looking placebo
It's important to remember that it is not currently approved for use by any health authority
With one in seven Americans now living in a household with a GLP-1 user, the impact extends beyond the individual because households share grocery bags, meal planning and eating occasions
However, you may reduce the dosage with the advice of doctor
week 1 continues with rest and light walking
Increasing evidence suggests that GLP-1R plays a critical role in maintaining cell metabolism homeostasis by improving mitochondrial function [56, 57]